CLX · XBRL financial data

The Clorox Company financial statements, every fiscal year

The same tables from 8 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (CLX's year ends in late June)

In millions of dollars	FY 2020Jun 30, 2020	FY 2021Jun 30, 2021	FY 2022Jun 30, 2022	FY 2023Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025
Revenue from contracts with customers	6,721	7,341	7,107	7,389	7,093	7,104
Cost of goods and services sold	3,658	4,142	4,562	4,481	4,045	3,891
Gross profit	3,063	3,199	2,545	2,908	3,048	3,213
Research and development	145	149	132	138	126	121
Selling, general and administrative	969	1,004	954	1,183	1,167	1,124
Interest expense	99	99	106	90	90	88
Income tax expense (benefit)	246	181	136	77	106	254
Net income (loss)	939	710	462	149	280	810
Earnings per share, basic USD per share	7.46	5.66	3.75	1.21	2.26	6.56
Earnings per share, diluted USD per share	7.36	5.58	3.73	1.20	2.25	6.52
Weighted average shares, basic millions of shares	126	126	123	124	124	124
Weighted average shares, diluted millions of shares	128	127	124	124	125	124

Fiscal years (CLX's year ends in late June)

In millions of dollars	FY 2020Jun 30, 2020	FY 2021Jun 30, 2021	FY 2022Jun 30, 2022	FY 2023Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025
Cash and cash equivalents	871	319	183	367	202	167
Accounts receivable	648	604	—	—	—	—
Inventory	454	752	755	696	637	523
Prepaid and other current assets	47	154	106	77	88	97
Total current assets	2,020	1,829	1,725	1,828	1,622	1,608
Property and equipment, net	1,103	1,302	1,334	1,345	1,315	1,267
Right-of-use asset	291	332	342	346	360	333
Goodwill	1,577	1,575	1,558	1,252	1,228	1,229
Total assets	6,213	6,334	6,158	5,945	5,751	5,561
Accounts payable	575	930	960	1,021	950	838
Commercial paper	0	0	237	50	4	4
Current portion of long-term debt	0	300	0	0	0	0
Total current liabilities	1,418	2,056	1,784	1,917	1,574	1,919
Long-term debt	2,780	2,484	2,474	2,477	2,481	2,484
Lease liability, non-current	278	301	314	310	334	305
Total liabilities	5,305	5,742	5,429	5,557	5,259	5,079
Retained earnings	3,567	1,036	1,048	583	250	432
Total stockholders' equity	908	411	556	220	328	321
Total liabilities and equity	6,213	6,334	6,158	5,945	5,751	5,561
Common shares outstanding (cover page) millions of shares	126	123	123	124	124	122

Fiscal years (CLX's year ends in late June)

In millions of dollars	FY 2020Jun 30, 2020	FY 2021Jun 30, 2021	FY 2022Jun 30, 2022	FY 2023Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025
Net income (loss)	939	710	462	149	280	810
Stock-based compensation	50	50	52	73	74	81
Depreciation and amortization	180	211	224	236	235	219
Net cash from operating activities	1,546	1,276	786	1,158	695	981
Purchases of property and equipment	254	331	251	228	212	220
Net cash from investing activities	(252)	(452)	(229)	(223)	(175)	(94)
Share repurchases	248	905	25	0	0	332
Dividends paid	533	558	571	583	595	602
Proceeds from long-term debt	492	0	1,085	0	0	—
Repayments of long-term debt	0	0	1,405	0	0	—
Net cash from financing activities	(523)	(1,391)	(689)	(753)	(655)	(924)
Net change in cash	766	(555)	(138)	182	(161)	(37)

SIC 2842 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Clorox	184	1,905	143	121.1M	Q1 FY27 10-QSep 30, 2026
Church & Dwight	447	1,602	380*	236.0M	Q3 FY26 10-QSep 30, 2026
Estee Lauder Companies	3,198	3,715	(166)	not reported	Q1 FY27 10-QSep 30, 2026
Kenvue	1,039	3,886	700*	1.9B	Q3 FY26 10-QSep 27, 2026
Ecolab	722	4,695	764*	280.5M	Q3 FY26 10-QSep 30, 2026
Colgate Palmolive	1,527	5,369	1,171*	794.9M	Q3 FY26 10-QSep 30, 2026
e.l.f. Beauty	344	479	112	59.0M	Q1 FY27 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.